Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at USA.gov.
Opioids and Chronic Pain—A Gap in Our Knowledge
September 25, 2014
Opioid prescriptions have increased three-fold over the past two decades, and we have seen how this skyrocketing availability of medications has helped create a new drug abusing population, some of whom suffer severe health consequences. More deaths now occur as a result of overdosing on prescription opioids than from all other drug overdoses combined, including heroin and cocaine. The opioid epidemic is tied closely to another epidemic in our country, that of chronic pain—although the ties are very complex.
Chronic pain now affects more than a third of Americans (see Infographic below). Although chronic pain patients themselves account for only a small percentage of those who are abusing opioid painkillers and dying from them, these pain sufferers may not even be obtaining significant benefit from the opioids used to treat their condition. In fact, growing evidence suggests that long-term treatment with opioids may induce hyperalgesia, an increase in pain sensitivity as a result of the chronic administration of opioid medications, at least in some patients.
Chronic pain is a major public health problem. It affects more than one-third of the U.S. and 20%-30% of the world's population. Prevalence of persistent pain is expected to rise with the increase in diabetes, cardiovascular disorders, obesity, arthritis and cancer in the aging U.S. population. Opioids can produce significant side effects such as respiratory depression, mental clouding, nausea, constipation and physical dependence. Opioid prescribing has increased 300% in the last 20 years. Today, the number of people who die from prescription opioids exceeds the number from heroin and cocaine combined. See a larger version from NIH Prevention site.
This year, the Agency for Healthcare Research and Quality reviewed studies on the effectiveness and risks of long-term opioid treatment of chronic pain. The results are eye-opening: No randomized trials or comparative observational studies meeting the reviewers’ criteria were found that addressed opioids’ effectiveness for chronic pain or comparing their effectiveness to other treatments, making it impossible to know whether long-term treatment with opioids adequately addresses patients’ symptoms or improves their functioning or quality of life. At best there was weak evidence regarding optimal dosing strategies with these medications.
I have argued before that opioids are overused and overprescribed because of a lack of clear understanding of how to treat pain by doctors. (Pain management is barely covered in medical schools—a situation that NIDA has worked to help rectify through various initiatives including leading the creation of 11 Centers of Excellence in Pain Education, in partnership with the NIH Pain Consortium and other NIH Institutes.) If it is indeed the case that opioid overtreatment is not only contributing to addiction but also contributing to the chronic pain problem, then that makes all the more urgent the need to investigate new treatment approaches and perhaps even create new medications that operate on other signaling systems in the body.
On September 29-30, NIDA along with the NIH Pain Consortium, the NIH Office of Disease Prevention, and the National Institute of Neurological Disorders and Stroke is cosponsoring a Pathways to Prevention workshop to discuss what we know and don’t know about opioids in the management of chronic pain. Participants will discuss the effectiveness and potential risks of long-term opioid treatment for different patient populations, different pain management strategies and their outcomes, ways of limiting opioids’ risks, and our future research needs.
Get more information on the workshop, The Role of Opioids in the Treatment of Chronic Pain. You can also see my video on pain research at NIDA and the NIH Pain Consortium (below).
Get this Publication
About This Blog
Welcome to my blog, here I highlight important work being done at NIDA and other news related to the science of drug abuse and addiction.
Dr. Nora Volkow: Video Highlights
- Charlie Rose, October 2017 - Opioid Addiction
- National Committee for Quality Assurance (NCQA): Quality Talks, October 2016
Treating Addiction Within the Health Care System
- APA TV, May 2016
APA TV chats with Dr. Nora Volkow, the Director of NIDA to hear about her lecture on drug abuse and the opioid epidemic.
- Kentucky Educational Television, May 2016
One to One with Bill Goodman: Dr. Nora Volkow
- TEDMED, January 2015
Why do our brains get addicted?
- The World Science Festival, April 2014
The Moth: The Brain's Addiction - Nora Volkow
- Rockburn Presents, November 2012
Dr. Nora Volkow
- Brookhaven National Laboratory WBNL Video, October 2012
Chemistry celebration: FDG: Contribution to Our Understanding of Addiction
- CBS 60 Minutes, April 2012
Hooked: Why Bad Habits Are Hard to Break
- Science Times, June 2011
Dr. Nora Volkow